Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair DeficiencyÉric Bouffet, Uri Tabori, Nataliya Zhukova et al.|Journal of Clinical Oncology|2016Cited by 867
Comprehensive Analysis of Hypermutation in Human CancerBrittany Campbell, Melyssa Aronson, Nicholas Light et al.|Cell|2017Cited by 795
Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug CombinationsMichal Yalon, Shoshana Paglin|PLoS ONE|2016Cited by 24
MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cellsZiv Versano, Michal Yalon|Oncotarget|2018Cited by 15
Pediatric glioblastoma - unlike normal cells - are sensitive to the combination of vorinostat and olaparib and to its downstream effector - phosphorylated eIF2αKarin Eytan, Michal Yalon|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 0